PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
December 1, 1995Clinical Chemistry319 citationsOpen Access

Cardiac troponin-I is not expressed in fetal and healthy or diseased adult human skeletal muscle tissue

View Full Paper
GBG. BodorDPD. Marshall PorterfieldEVEllen M. Voss

Key Result

Cardiac troponin-I was not detectable by immunoassay or immunohistochemistry in any normal fetal, normal adult, or diseased (polymyositis, Duchenne muscular dystrophy) skeletal muscle samples.

Study Design

Type

Observational (n=33)

Structured PICO

Is cardiac troponin-I expressed in normal or diseased regenerating human skeletal muscle tissue?

P
Population
33 human muscle tissue samples including human heart tissue (n=5), normal adult skeletal muscle (n=3), fetal heart (n=3), fetal skeletal muscle (n=3), polymyositis skeletal muscle (n=13), and Duchenne muscular dystrophy skeletal muscle (n=6).
I
Intervention
Immunohistochemical staining (using monoclonal antibodies 2B1.9 and 3C5.10) and immunofluorometric assay for cardiac troponin-I (cTnI)
O
Outcome
Expression of cardiac troponin-I (cTnI) in tissuesurrogate

Cardiac troponin-I is not expressed in normal or regenerating human skeletal muscle, confirming its high specificity as a biomarker for myocardial injury.

Abstract

Cardiac troponin-I (cTnI) is not found in sera of patients with skeletal muscle disease in the absence of myocardial injury. It is not known, however, whether trace amounts of cTnI are expressed in regenerating human skeletal muscle, as has been observed with creatine kinase MB. Using immunohistochemical and biochemical techniques, we investigated cTnI expression in various human muscle tissues: human heart tissue (n = 5), normal adult skeletal muscle (n = 3), and fetal heart (n = 3) and skeletal muscle (n = 3) obtained, respectively, during heart transplant, from autopsy, or from a tissue bank. Specimens from diagnostic tissue biopsies were used as diseased skeletal muscle: polymyositis (PM), n = 13; Duchenne muscular dystrophy (DMD), n = 6. Frozen sections 8 microns thick were stained immunohistochemically for either cTnI or TnI (cardiac or skeletal) by using monoclonal antibodies (MAb) 2B1.9 (cTnI specific) or 3C5.10 (reactive with all TnI isoforms), respectively. cTnI was measured in tissue homogenates by an immunofluorometric assay. Cardiac muscle was stained by both MAbs. Normal fetal and adult skeletal muscle, and samples from all of the PM and DMD patients, stained only with the nonspecific MAb (3C5.10), confirming the sole presence of skeletal TnI. No cTnI was detectable by immunoassay in any skeletal muscle sample. We conclude that cTnI is not expressed in human skeletal muscle during development or during regenerative muscle disease processes such as PM or DMD.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Bodor et al. (1995) conducted an observational in Skeletal muscle disease (Polymyositis, Duchenne muscular dystrophy) (n=33). Immunohistochemical and biochemical analysis vs. Cardiac muscle tissue (positive control) was evaluated on Expression of cardiac troponin-I (cTnI). Cardiac troponin-I was not detectable by immunoassay or immunohistochemistry in any normal fetal, normal adult, or diseased (polymyositis, Duchenne muscular dystrophy) skeletal muscle samples.

synapsesocial.com/papers/6a125ad31292a1e50c34b964https://doi.org/10.1093/clinchem/41.12.1710
Ask AI
Helpful
Bookmark
Share
View Full Paper